Modelon’s Q3 2023 report contained no big surprises. The ARR was exactly in line with our estimates and sales were close. The ongoing transition from on-premise installations of the flagship product Modelon Impact to more streamlined and managed cloud services is temporarily extending sales cycles, but we believe Modelon is set to pick-up pace in 2024. We make some adjustments to our estimates following the report, mainly on the growth side.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases